Market Research Report
Computational Medicine and Drug Discovery Software Market: By Tools (Software, Databases and Others); By Application (Drug Discovery and Development, Disease Modeling, Medical Imaging and Others) & By Geography - 2019-2024
|Published by||IndustryARC||Product code||351092|
Delivery time: 2-3 business days
|Computational Medicine and Drug Discovery Software Market: By Tools (Software, Databases and Others); By Application (Drug Discovery and Development, Disease Modeling, Medical Imaging and Others) & By Geography - 2019-2024|
|Published: December 21, 2018||Content info:||
Computational Medicine and Drug Discovery Software, as the name suggests, is an interdisciplinary subject that goes for creating innovative solutions for important clinical problems to improve human health. There are many clinical applications of computational medicine which help in the process of data collection and development of tools for clinical decision making. Computational Medicine finds its roots in chemistry and quantum mechanics. The foundation of computational medicine is based upon database and constraint-based models. Database is basically repositories of information which is used in constraint-based models to understand protein-ligand interaction. The global market for computational medicine and drug discovery software was estimated to be $5.2 billion in 2015 and is projected to escalate to $7.1 billion by 2021.
The computational medicine and drug discovery software market has been extensively studied based on several differentiating parameters to provide a comprehensive overview. The market has been segmented based on following parameters: tools, application and geography. Each of the categories has been further segregated into specific sub-divisions to consider the dynamics associated with this industry. Based on tools, software remained pre-dominant choice in 2015 followed by database. The applications considered in the report include computational physiological medicine, drug discovery and development, medical imaging, disease modeling, predictive analysis of drug targets, cellular simulation and simulation software. A similar strategy was followed to investigate the industry dynamics for computational medicine and drug discovery software specific to eminent countries that constituted the overall regional market including Americas, Europe, Asia-Pacific (APAC) and Rest of the World (RoW).
In 2015, the market share for medical imaging was 38.3% and is projected to grow at a CAGR of 4.2% during the forecast period. The main driving factor for the market are rising bioinformatics in drug discovery, three dimensional drug discovery methodology evolution and increase in late stage drug discovery failure.
More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"